Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-393-1 | CAS number: 120-40-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Reason / purpose for cross-reference:
- reference to other study
- Principles of method if other than guideline:
- Suspensions of bacterial cells were exposed to the test substance by the plate incorporation method in the presence and in the absence of an exogenous metabolic activation system. The suspensions were mixed with an overlay agar and plated immediately onto the minimal medium and incubated for 2 d at 37˚C. The results were interpreted by counting the revertant colonies and comparing to the number of spontaneous revertant colonies on solvent-control plates.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- other: S. typhimurium TA97, TA98, TA100 and TA1535
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix (metabolic activation enzymes and cofactors from Aroclor 1254-induced male Sprague-Dawley rat or Syrian hamster liver).
- Test concentrations with justification for top dose:
- - without metabolic activation:0.0, 0.3, 1.0, 3.0, 10.0, 33.0, 66.0, 100.0, 333.0 µg/plate
- with metabolic activation: 0.0, 1.0, 3.0, 10.0, 33.0, 100.0, 166.0, 333.0, 1,000.0 µg/plate - Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- yes
- Remarks:
- solvent control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- -S9 : for strains TA100 and TA1535
- Untreated negative controls:
- yes
- Remarks:
- solvent control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- -S9 : for strain TA97
- Untreated negative controls:
- yes
- Remarks:
- solvent control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-o- phenylenediamine
- Remarks:
- -S9 : for strain TA98
- Untreated negative controls:
- yes
- Remarks:
- solvent control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- +S9 : all strains
- Details on test system and experimental conditions:
- - Test medium: Top agar supplemented with L-histidine and d-biotin
- Method of application: In agar (plate incorporation)
- Duration of incubation: 2 d at 37°C
- Number of replicates: Three - Evaluation criteria:
- - Positive response: Reproducible, dose-related increase in histidine-independent (revertant) colonies in any one strain/activation combination.
- Equivocal response: An increase in revertants that are not dose related, is not reproducible, or is not of sufficient magnitude to support a determination of m utagenicity.
- Negative response: When no increase in revertant colonies is observed following chemical treatment. - Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- not specified
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Key result
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at ≥ 66 µg/plate without metabolic activation; at 1000 µg/plate with metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at ≥ 66 µg/plate without metabolic activation; at 1000 µg/plate with metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at ≥ 66 µg/plate without metabolic activation; at 1,000 µg/plate with metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at ≥ 66 µg/plate without metabolic activation; at 1,000 µg/plate with metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Conclusions:
- Under the study conditions, the test substance was not mutagenic.
- Executive summary:
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, according to a design based on OECD Guidance 471, in compliance with GLP. Salmonella typhimurium strains TA97, TA98, TA100 and TA1535 were treated with the test substance using the Ames plate incorporation method at up to eight dose levels, in triplicate, both with and without the addition of S9 mix (Aroclor-induced rat and hamster liver homogenate-metabolising system). The dose range was 0.3 to 333 µg/plate (without S9-mix) and 1 to 1000 µg/plate (with S9-mix). Cytotoxicity was observed at ≥66 µg/plate without metabolic activation and at 1000 µg/plate with metabolic activation. No significant increase in the frequency of revertant colonies was recorded for any of the bacterial strains with any dose of the test substance, either with or without metabolic activation. The vehicle control (ethanol) or the negative control plates produced counts of revertant colonies within the normal range. All the positive control chemicals used in the test produced marked increases in the frequency of revertant colonies, both with and without S9-mix. Under the study conditions, the test substance was not mutagenic (NTP, 1999).
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Reason / purpose for cross-reference:
- reference to other study
- Principles of method if other than guideline:
- The genotoxic potential of the test substance was determined by the induction of chromosomal aberrations in Chinese Hamster Ovary Cells both with and without metabolic activation.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- No data
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced male Sprague-Dawley rat liver S9 and cofactor mix
- Test concentrations with justification for top dose:
- 4.99, 15.00, 49.90 and 100.00 µg/mL (without S9);
1.50, 4.99, 15.00 and 30.00 µg/mL (with S9) - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- (Ethanol)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- Without S9, at 1 and 5 µg/mL
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- (Ethanol)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- With S9, at 50 µg/mL
- Details on test system and experimental conditions:
- Detailed protocol of this study has been presented by (Galloway et al (1987)).
DURATION
- Exposure duration: In the test without S9, cells were incubated in McCoy’s 5A medium with lauric acid diethanolamine condensate for 8 h; Colcemid was added and incubation continued for 2 h. For the test with S9, cells were treated with lauric acid diethanolamine condensate and S9 for 2 h, after which the treatment medium was removed and the cells were incubated for 10 h in fresh medium, with Colcemid present for the final 2 h. The cells were then harvested by mitotic shake-off, fixed, and stained with Giemsa.
- Harvest time: 10 h (without S9); 12 h (with S9)
NUMBER OF REPLICATIONS: A single flask per dose was used, and tests yielding equivocal or positive results were repeated.
NUMBER OF CELLS EVALUATED: Two hundred first-division metaphase cells were scored at each dose level.
OTHER: Cells were selected for scoring on the basis of good morphology and completeness of karyotype (21 ± 2 chromosomes). All slides were scored blind and those from a single test were read by the same person. Classes of aberrations included simple (breaks and terminal deletions), complex (rearrangements and translocations), and other (pulverised cells, despiralised chromosomes, and cells containing 10 or more aberrations). - Evaluation criteria:
- No data
- Statistics:
- Statistical analyses were conducted on both the dose response curve and individual dose points. For a single trial, a statistically significant (P ≤0.05) difference for one dose point and a significant trend (P ≤0.015) were considered weak evidence for a positive response; significant differences for two or more doses indicates the trial was positive. A positive trend test in the absence of a statistically significant increase at any one dose resulted in an equivocal call.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Additional information on results:
- None
- Conclusions:
- Under the study conditions, the test substance was found to be non-mutagenic.
- Executive summary:
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, in a chromosomal aberration assay using Chinese Hamster Ovary (CHO) cells. The concentrations tested were 4.99, 15.00, 49.90 and 100.00 µg/mL without S9 and 1.50, 4.99, 15.00 and 30.00 µg/mL with S9. Concurrent solvent and positive controls (mitomycin-C (without S9) and cyclophosphamide (with S9)) were also included. A single flask per concentration was used and two hundred first-division metaphase cells were scored at each concentration level. The test substance did not induce an increase in the number of chromosomal aberrations. Under the study conditions, the test substance was found to be non-mutagenic (NTP, 1999).
- Endpoint:
- in vitro DNA damage and/or repair study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Reason / purpose for cross-reference:
- reference to other study
- Principles of method if other than guideline:
- The genotoxic potential of the test substance was determined by the induction of sister chromatid exchanges in Chinese Hamster Ovary Cells both with and without metabolic activation.
- GLP compliance:
- yes
- Type of assay:
- sister chromatid exchange assay in mammalian cells
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- No data
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced male Sprague-Dawley rat liver S9 and cofactor mix.
- Test concentrations with justification for top dose:
- - Without S9 mix: Trial 1: 2.49, 4.97, 14.90, 49.70 μg/mL; Trial 2: 5.0, 10.0, 15.0, 20.0, 30.0 μg/mL.
- With S9 mix: Trial 1: 2.50, 8.35, 25.0, 83.50 μg/mL; Trial 2: 10.0, 15.0, 20.0, 30.0 μg/mL. - Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- yes
- Remarks:
- solvent control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- -S9: at concentrations of 0.002 and 0.010 μg/mL in trials 1 and 2
- Untreated negative controls:
- yes
- Remarks:
- solvent control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- +S9 : at concentrations of 0.050 and 2.50 μg/mL in trial 1 and 0.75 and 2.50 μg/mL in trial 2
- Details on test system and experimental conditions:
- - Cultures were handled under gold lights to prevent photolysis of bromodeoxyuridine-substituted DNA.
- Details for SCE test without S9: CHO cells were incubated for 26 hours with the test substance in supplemented McCoy’s 5A medium. Bromodeoxyuridine (BrdU) was added 2 hours after culture initiation. After 26 hours, the medium containing the test substance was removed and replaced with fresh medium plus BrdU and Colcemid, and incubation was continued for 2 hours. Cells were then harvested by mitotic shake-off, fixed, and stained with Hoechst 33258 and Giemsa.
- Details on SCE test with S9: Cells were incubated with the test substance, serum-free medium, and S9 for 2 hours. The medium was then removed and replaced with medium containing serum and BrdU and no test substance. Incubation proceeded for an additional 26 hours, with Colcemid (spindle inhibitor) present for the final 2 hours. Harvesting and staining were the same as for cells treated without S9.
- Number of replications: A single flask per dose was used, and tests yielding equivocal or positive results were repeated.
- Scoring and number of cells evaluated: All slides were scored blind and those from a single test were read by the same person. Fifty second-divisionmetaphase cells were scored for frequency of SCEs/cell from each dose level. - Evaluation criteria:
- - Statistically conservative positive response: When an SCE frequency was 20% above the concurrent solvent control value at two or more doses.
- Weak response: When an increase of 20% or greater is observed at any single dose.
- Equivocal response: A statistically significant (P<0.005) absence of any responses reaching 20% above background. - Statistics:
- Statistical analyses were conducted on the slopes of the dose-response curves and the individual dose points (i.e., by the linear regression trend test versus log of the dose).
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Remarks:
- (Test substance induced sister chromatid exchanges both in the presence and absence of S9).
- Cytotoxicity / choice of top concentrations:
- not specified
- Conclusions:
- Under the study conditions, the test substance was shown to induce sister chromatid exchanges both in the presence and absence of S9.
- Executive summary:
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, in a sister chromatid exchanges assay using Chinese Hamster Ovary (CHO) cells. The concentration studied were 2.49, 4.97, 14.90, 49.70 μg/mL in Trial 1 and 5.0, 10.0, 15.0, 20.0, 30.0 μg/mL in Trial 2 (without S9); 2.50, 8.35, 25.0, 83.50 μg/mL in Trial 1 and 10.0, 15.0, 20.0, 30.0 μg/mL in Trial 2 (with S9). Concurrent solvent and positive controls (mitomycin-C (without S9) and cyclophosphamide (with S9)) were also included. A single flask per concentration was used and fifty second-division metaphase cells were scored at each dose level. Under the study conditions, the test substance was shown to induce sister chromatid exchanges both in the presence and absence of S9 (NTP, 1999).
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Reason / purpose for cross-reference:
- reference to other study
- Principles of method if other than guideline:
- Cells deficient in thymidine kinase (TK) due to the mutation of TK+/- to TK-/- are resistant to the cytotoxic effects of trifluorothymidine (TFT). Thymidine kinase proficient cells (TK+/-) are sensitive to TFT, which causes the inhibition of cellular metabolism and halts further cell division. Thus mutant cells are able to proliferate in the presence of TFT, whereas normal cells, which contain thymidine kinase, are not able to proliferate.
- GLP compliance:
- no
- Type of assay:
- mammalian cell gene mutation assay
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Supplemented Fischer’s medium
- Properly maintained: Yes
- Periodically "cleansed" against high spontaneous background: Yes, by exposing to medium containing thymidine, hypoxanthine, methotrexate, and glycine for 1 d; to medium containing thymidine, hypoxanthine, and glycine for 1 d; and to normal medium for 3 to 5 d - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from the livers of Aroclor 1254-induced male Fischer 344 rats
- Test concentrations with justification for top dose:
- Trial 1:
Without metabolic activation: 2.5, 5, 10, 20, 30, 40 and 50 μg/mL
With metabolic activation: 5, 10, 20, 30, 40, 50 and 60 μg/mL
Trial 2:
Without metabolic activation: 5, 10, 20 and 30 μg/mL
With metabolic activation: 5, 10, 20, 30 and 40 μg/mL - Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- (Ethanol)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- -S9 : 5 μg/mL in both trials 1 and 2
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- (Ethanol)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Methyl cholanthrene
- Remarks:
- +S9 : 2.5 μg/mL in both trials 1 and 2
- Details on test system and experimental conditions:
- The experimental protocol is presented in detail by Myhr et al, 1985
METHOD OF APPLICATION: In medium
DURATION
- Exposure duration: 4 h
- Expression time (cells in growth medium): 48 h
- Selection time (if incubation with a selection agent): 10 to 12 d (at 37°C in 5% CO2)
SELECTION AGENT (mutation assays): Yes, Trifluorothymidine (TFT)
NUMBER OF REPLICATIONS: Duplicate (all treatment levels within an experiment, including concurrent positive and solvent controls, were replicated)
NUMBER OF CELLS EVALUATED: 6 × 10(6) cells in 10 mL medium
DETERMINATION OF CYTOTOXICITY
- Method: Cloning efficiency - Evaluation criteria:
- Minimum criteria for accepting an experiment as valid and a detailed description of the statistical analysis and data evaluation are presented by Caspary et al. (1988). Both responses would have to be significant (P≤0.05) for test material to be considered positive, i.e., capable of inducing TFT resistance. A single significant response would lead to a call of “questionable,” and the absence of both a trend and peak response results in a “negative” call.
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Additional information on results:
- No increase in the frequency of mutant colonies of L5178Y mouse lymphoma cells was noted after exposure to test material, with or without S9.
- Conclusions:
- Under the study conditions, the test substance was found to be non-mutagenic.
- Executive summary:
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, in a mouse lymphoma assay. The cells were exposed for 4 h to concentrations of 2.5, 5, 10, 20, 30, 40 and 50 μg/mL without metabolic activation and 5, 10, 20, 30, 40, 50 and 60 μg/mL with metabolic activation in Trial 1. Cells were treated with test substance for 4 h at 5, 10, 20, 30, 40 μg/mL with metabolic activation and 5, 10, 20, 30 without metabolic activation in Trial 2. After the 48 h expression period, cells were plated in medium and soft agar supplemented with TFT for selection of TFT-resistant cells and cells were plated in nonselective medium and soft agar to determine cloning efficiency. Under the test conditions, no increase in the frequency of mutant colonies of L5178Y mouse lymphoma cells was noted after exposure to test substance, with or without S9. Under the study conditions, the test substance was found to be non-mutagenic (NTP, 1999).
Referenceopen allclose all
For detailed results table kindly refer to the attached background materials section of the IUCLID.
Table 1: Induction of Chromosomal Aberrations in Chinese Hamster Ovary Cells (Loveday KS et al (1990))
Compound |
Concentration (µg/mL) |
Total Cells Scored |
Number of Aberrations |
Aberrations/Cell |
Cells with Aberrations (%) |
Without S9 |
|||||
Solvent control |
200 |
7 |
0.04 |
2.5 |
|
Mitomycin-Ca |
1 |
200 |
33 |
0.17 |
15.5 |
|
5 |
50 |
53 |
1.06 |
58 |
Lauric acid diethanolamine condensate |
4.99 |
200 |
9 |
0.05 |
4 |
|
15 |
200 |
3 |
0.02 |
1.5 |
|
49.9 |
200 |
1 |
0.01 |
0.5 |
|
P=0.969b |
||||
With S9 |
|||||
Solvent control |
200 |
10 |
0.05 |
4 |
|
Cyclophosphamide 50a |
50 |
50 |
119 |
2.3 |
72 |
Lauric acid diethanolamine condensate |
1.5 |
200 |
398.5 |
597 |
3.5 |
|
4.99 |
200 |
395.01 |
590.02 |
5 |
|
15 |
200 |
9 |
0.05 |
3.5 |
|
30 |
0 |
|||
|
P=0.494 |
a = Positive control
b = Significance of percent cells with aberrations tested by the linear regression trend test versus log of the dose.
For detailed results table kindly refer to the attached background materials section of the IUCLID.
For detailed results table kindly refer to the attached background materials section of the IUCLID.
For detailed results table kindly refer to the attached background materials section of the IUCLID.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not available
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Reason / purpose for cross-reference:
- reference to other study
- Principles of method if other than guideline:
- The test substance was applied dermally to mice for 14 weeks. Peripheral blood samples were obtained from male and female mice at termination, and smears were immediately prepared and slides were scanned to determine the frequency of micronuclei.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farms, Germantown, NY
- Age at study initiation: 7 wk
- Housing: Housed individually in Polycarbonate cages
- Bedding: Sani-Chip heat-treated hardwood chips (P.J. Murphy Forest Products Corp., Montville, NJ)
- Diet : NIH-07 open formula pelleted diet, ad libitum
- Water : Tap water, ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature : 21.1-23.9°C
- Humidity : 42- 57%
- Air changes : 10/hr
- Photoperiod : 12 h dark/12 h light
IN-LIFE DATES: From: 1992-01-15 To: 1992-04-17 - Route of administration:
- dermal
- Vehicle:
- - Vehicle(s)/solvent(s) used: Ethanol
- Concentration of test material in vehicle:
- Lot/batch no. (if required): 91D22U
- Purity: Purity of the bulk ethanol ranged from 97% to 103% relative to the reference standard - Duration of treatment / exposure:
- 14 wk
- Frequency of treatment:
- 5 exposures/wk
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 50 mg/kg bw/day (nominal)
- Remarks:
- Corresponding to 20 mg/mL in ethanol
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Remarks:
- Corresponding to 40 mg/mL in ethanol
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Remarks:
- Corresponding to 80 mg/mL in ethanol
- Dose / conc.:
- 400 mg/kg bw/day (nominal)
- Remarks:
- Corresponding to 160 mg/mL in ethanol
- Dose / conc.:
- 800 mg/kg bw/day (nominal)
- Remarks:
- Corresponding to 320 mg/mL in ethanol
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Tissues and cell types examined:
- Tissues - Peripheral blood.
Cells - Normochromatic erythrocytes.
Slides were scanned to determine the frequency of micronuclei in 2000 Normochromatic erythrocytes (NCEs) in each of five animals per dose group.
- Details of tissue and slide preparation:
- A detailed discussion of this assay is presented by MacGregor et al, 1990.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): Blood samples collected at the end of 14 wk study period
DETAILS OF SLIDE PREPARATION: Peripheral blood samples smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. - Evaluation criteria:
- An individual trial is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dose group is less than or equal to 0.025 divided by the number of dose groups.
- Statistics:
- The frequency of micronucleated cells among NCEs was analyzed by a statistical software package that tested for increasing trend over dose groups with a one-tailed Cochran- Armitage trend test, followed by pairwise comparisons between each dosed group and the control group. In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation.
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Conclusions:
- Under the study conditions, the test substance did not increase the frequency of micronuclei in peripheral blood cells of mice.
- Executive summary:
A study was conducted to evaluate the in vivo genetic toxicity of the test substance, C12 DEA, in a peripheral blood micronucleus assay. The substance was applied dermally to mice for 14 weeks with a frequency of 5 exposures/week at doses of 50, 100, 200, 400 and 800 mg/kg bw. Peripheral blood samples were obtained from male and female mice, and smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. Slides were scanned to determine the frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each of five animals per dose group. No increase in the frequency of micronucleated normochromatic erythrocytes was observed in the test at any dose level. Under the study conditions, the test substance did not increase the frequency of micronuclei in peripheral blood cells of mice (NTP, 1999).
Reference
For detailed results table kindly refer to the attached background materials section of the IUCLID.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro
Ames test
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, according to a design based on OECD Guidance 471, in compliance with GLP. Salmonella typhimurium strains TA97, TA98, TA100 and TA1535 were treated with the test substance using the Ames plate incorporation method at up to eight dose levels, in triplicate, both with and without the addition of S9 mix (Aroclor-induced rat and hamster liver homogenate-metabolising system). The dose range was 0.3 to 333 µg/plate (without S9-mix) and 1 to 1000 µg/plate (with S9-mix). Cytotoxicity was observed at ≥66 µg/plate without metabolic activation and at 1000 µg/plate with metabolic activation. No significant increase in the frequency of revertant colonies was recorded for any of the bacterial strains with any dose of the test substance, either with or without metabolic activation. The vehicle control (ethanol) or the negative control plates produced counts of revertant colonies within the normal range. All the positive control chemicals used in the test produced marked increases in the frequency of revertant colonies, both with and without S9-mix. Under the study conditions, the test substance was not mutagenic (NTP, 1999).
Chromosomal aberration assay
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, in a chromosomal aberration assay using Chinese Hamster Ovary (CHO) cells. The concentrations tested were 4.99, 15.00, 49.90 and 100.00 µg/mL without S9 and 1.50, 4.99, 15.00 and 30.00 µg/mL with S9. Concurrent solvent and positive controls (mitomycin-C (without S9) and cyclophosphamide (with S9)) were also included. A single flask per concentration was used and two hundred first-division metaphase cells were scored at each concentration level. The test substance did not induce an increase in the number of chromosomal aberrations. Under the study conditions, the test substance was found to be non-mutagenic (NTP, 1999).
Sister chromatid exchange assay
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, in a sister chromatid exchanges assay using Chinese Hamster Ovary (CHO) cells. The concentration studied were 2.49, 4.97, 14.90, 49.70 μg/mL in Trial 1 and 5.0, 10.0, 15.0, 20.0, 30.0 μg/mL in Trial 2 (without S9); 2.50, 8.35, 25.0, 83.50 μg/mL in Trial 1 and 10.0, 15.0, 20.0, 30.0 μg/mL in Trial 2 (with S9). Concurrent solvent and positive controls (mitomycin-C (without S9) and cyclophosphamide (with S9)) were also included. A single flask per concentration was used and fifty second-division metaphase cells were scored at each dose level. Under the study conditions, the test substance was shown to induce sister chromatid exchanges both in the presence and absence of S9 (NTP, 1999).
Mouse lymphoma assay
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C12 DEA, in a mouse lymphoma assay. The cells were exposed for 4 h to concentrations of 2.5, 5, 10, 20, 30, 40 and 50 μg/mL without metabolic activation and 5, 10, 20, 30, 40, 50 and 60 μg/mL with metabolic activation in Trial 1. Cells were treated with test substance for 4 h at 5, 10, 20, 30, 40 μg/mL with metabolic activation and 5, 10, 20, 30 without metabolic activation in Trial 2. After the 48 h expression period, cells were plated in medium and soft agar supplemented with TFT for selection of TFT-resistant cells and cells were plated in nonselective medium and soft agar to determine cloning efficiency. Under the test conditions, no increase in the frequency of mutant colonies of L5178Y mouse lymphoma cells was noted after exposure to test substance, with or without S9. Under the study conditions, the test substance was found to be non-mutagenic (NTP, 1999).
In vivo
Mouse micronucleus assay
A study was conducted to evaluate the in vivo genetic toxicity of the test substance, C12 DEA, in a peripheral blood micronucleus assay. The substance was applied dermally to mice for 14 weeks with a frequency of 5 exposures/week at doses of 50, 100, 200, 400 and 800 mg/kg bw. Peripheral blood samples were obtained from male and female mice, and smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. Slides were scanned to determine the frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each of five animals per dose group. No increase in the frequency of micronucleated normochromatic erythrocytes was observed in the test at any dose level. Under the study conditions, the test substance did not increase the frequency of micronuclei in peripheral blood cells of mice (NTP, 1999).
Justification for classification or non-classification
C12 DEA was predominantly negative in short-term in vitro and in vivo genotoxicity tests. Although one in vitro cytogenicity study reported an increase in the incidence of sister chromatid exchange in CHO cells treated with the test substance, both in the presence and absence of metabolic activation, the number of chromosomal aberrations was not increased in CHO cells exposed to similar concentrations of the test substance with or without S9. Furthermore, no increase in the frequency of micronucleated normochromatic erythrocytes was observed in an in vivo micronucleus assay in mice. Based on the overall weight of evidence, C12 DEA is not expected to have any genotoxic potential. Therefore, no classification is required for genotoxicity according to CLP (EC 1272/2008) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.